Re: Great Presetation today

...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Reply New Message

Prev Message Back To Forum Threaded View Next Message

tada

Rank: President [?]

Points: 7750 [?]

Votes: 40 Score: 3.4 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Re: Great Presetation today

in response to

Re: Great Presetation today

fouremm

posted on Oct 20, 2017 02:04AM

fouremm - That is certainly the way I understand it. I confirmed my understanding with three different brokers who seem to be close to this story as well.